
Opinion|Videos|August 14, 2024
JAK Inhibitors and Myelofibrosis Management: A Review of Current Treatments
Dr Mahmoudjafari provides an overview of JAK inhibitors available for the treatment of patients with myelofibrosis.
Advertisement
Episodes in this series

Video content above is prompted by the following question:
- How have JAK inhibitors impacted the management of myelofibrosis? Please discuss the current armamentarium of JAK inhibitors approved for the treatment of myelofibrosis:
Advertisement
Advertisement
Advertisement
Trending on Managed Healthcare Executive
1
Researchers discover new pathway to fight liver inflammation
2
Weekly autoinjector Leqembi is available for treatment initiation in Alzheimer’s
3
Employer health care costs projected to rise 9.5% in 2027, report finds
4
Anti-inflammatories instead of antifungals for seborrheic dermatitis
5






















